MARICO · NSE

Marico Limited

₹803.9

-1.60% (-₹13.1)

Prev. close

₹817

Volume

28,48,872

Delivery %

74.8%

As of

18 Sept 2026

Price history

₹803.9-₹16 (-1.95%) · 3M
10 Jun 202618 Sept 2026
₹880.95₹791.2510 Jun03 Jul03 Aug26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Marico Limited in the last 90 days.

Fundamentals

About Marico Limited

Marico Limited, together with its subsidiaries, manufactures and sells branded consumer products in India, Bangladesh, Vietnam, and internationally. It offers coconut oils, refined edible oils, hair oils, anti-lice treatments, fabric care, functional and other processed food, hair creams and gels, hair serums, shampoos, conditioners, shower gels, hair relaxers and straighteners, deodorants, female personal care, baby care, skin care, male grooming and hair styling, packaged food, health care, and hygiene products. The company markets its products under the Parachute, Parachute Advansed, Saffola, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Just Herbs, True Elements, Kaya, Beardo, and Plix, HairCode, Fiancée, Purité de Prôvence, Ôliv, Lashe', Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Studio X, Thuan Phat and Isoplus brand names. It sells its products through distribution network, including regional offices, carrying and forwarding agents, redistribution centers, and distributors. Marico Limited was incorporated in 1988 and is headquartered in Mumbai, India.

Details

Sector

Consumer Defensive

Industry

Household & Personal Products

CEO

Mr. Saugata Gupta

Headquarters

Mumbai

Employees

1,983

Website

marico.com

Key stats

Market cap

₹1.04 L Cr

P/E ratio (TTM)

55.3

Dividend yield

0.49%

EPS (TTM)

₹14.54

Beta (1Y · daily vs NIFTY 50)

0.51

Beta (5Y · monthly vs NIFTY 50)

0.60

Shares float

55.17 Cr

EPS · quarter ended Jun 2026

₹4.85

Upcoming earnings

12 Nov 2026

Financial Performance

01 · Financials

0 Cr5000 Cr10000 Cr15000 Cr-20%0%20%40%FY21FY22FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

FY21 growth needs FY20 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

051015FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0358-100%0%100%200%06 Feb 2016 Mar 2005 Nov 2010 Mar 2108 Nov 2104 Feb 2208 Mar 2307 Nov 2306 Mar 2407 Feb 2501 Aug 2530 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-20%0%20%40%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr2500 Cr5000 Cr7500 Cr10000 Cr0.5×1.5×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr2500 Cr5000 Cr7500 Cr10000 CrFY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

0 Cr1000 Cr2000 Cr3000 CrFY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹8,048.00 Cr₹9,512.00 Cr₹9,764.00 Cr₹9,653.00 Cr₹10,831.00 Cr₹13,611.00 Cr
EBITDA₹1,685.00 Cr₹1,779.00 Cr₹1,954.00 Cr₹2,168.00 Cr₹2,347.00 Cr₹2,532.00 Cr
₹1,172.00 Cr₹1,225.00 Cr₹1,302.00 Cr₹1,481.00 Cr₹1,629.00 Cr₹1,762.00 Cr
Diluted EPS₹9.08₹9.49₹10.05₹11.43₹12.56₹13.59

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹5,426.00 Cr₹5,677.00 Cr₹6,800.00 Cr₹7,353.00 Cr₹8,275.00 Cr₹9,950.00 Cr
₹608.00 Cr₹528.00 Cr₹554.00 Cr₹557.00 Cr
Stockholders' equity₹3,240.00 Cr₹3,348.00 Cr₹3,799.00 Cr₹3,832.00 Cr₹3,975.00 Cr₹4,210.00 Cr

Current assets, Inventory, Trade receivables, Cash & equivalents, Non-current assets, CWIP, Others, Total debt, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹2,353.00 Cr₹1,016.00 Cr₹1,419.00 Cr₹1,387.00 Cr₹1,363.00 Cr₹2,084.00 Cr
Investing cash flow₹-1,223.00 Cr₹428.00 Cr₹-865.00 Cr₹176.00 Cr₹-621.00 Cr₹-722.00 Cr
₹-1,119.00 Cr₹-1,290.00 Cr₹-560.00 Cr₹-1,542.00 Cr₹-649.00 Cr₹-1,279.00 Cr
Capital expenditure₹-142.00 Cr₹-132.00 Cr₹-182.00 Cr₹-153.00 Cr₹-161.00 Cr₹-319.00 Cr
End cash position₹207.00 Cr₹228.00 Cr₹321.00 Cr₹404.00 Cr

Debt issued, Debt repaid, End cash position have filed figures for only some of the years shown — no further verified source covers the rest, so those years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21Dec 21Mar 22Jun 22Sep 22(2Q)Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26
Promoter59.52%59.51%59.49%59.48%59.48%59.42%59.42%59.40%59.39%59.35%59.28%59.20%59.11%59.05%59.03%58.94%58.93%58.93%58.91%
Public40.38%40.40%40.40%40.41%40.43%40.47%40.48%40.49%40.53%40.54%40.61%40.69%40.81%40.83%40.85%40.80%40.85%40.88%40.91%
Employee trusts0.10%0.10%0.11%0.11%0.09%0.11%0.11%0.11%0.08%0.11%0.11%0.11%0.08%0.12%0.12%0.26%0.22%0.19%0.17%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Consumer Defensive

Company
Hindustan Unilever Limited₹4.56 L Cr₹1,93243.79.3630.9%0.03+5.3%-25.3%
ITC Limited₹3.34 L Cr₹262.316.84.6028.5%0.03+4.8%-36.3%
Nestle India Limited₹2.67 L Cr₹1,383.369.966.5280.0%0.29+19.6%+14.1%
Avenue Supermarts Limited₹2.42 L Cr₹3,749.979.49.8912.1%0.10+16.0%-21.2%
Varun Beverages Limited₹1.41 L Cr₹421.9541.57.1815.5%0.13+7.1%-10.9%
Britannia Industries Limited₹1.20 L Cr₹4,98245.723.5849.6%0.27+7.5%-18.3%
Marico Limited₹1.06 L Cr₹803.956.025.1941.9%0.13+26.2%+11.7%
TATA CONSUMER PRODUCTS LIMITED₹98,978.89 Cr₹1,013.760.44.547.1%0.13+15.2%-10.8%
United Spirits Limited₹98,697.70 Cr₹1,37158.511.0220.5%0.05+7.8%+3.3%
Godrej Consumer Products Limited₹89,334.52 Cr₹88046.67.0614.7%0.35+8.5%-28.9%
Dabur India Limited₹67,765.15 Cr₹384.5534.75.9316.6%0.11+5.2%-28.1%
Radico Khaitan Limited₹58,684.29 Cr₹4,535.483.117.7018.2%0.24+24.8%+50.7%

Ranked by market cap within Consumer Defensive, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

Index membership

66 indices

NSE weights are a free-float market-cap-share estimate, not NSE’s own published (and sometimes capped) index weight. BSE weights are BSE’s own published index weight, not an estimate. Indices without weight data are listed without one, in alphabetical order after the weighted ones.

MARICO

Patanjali Foods, ITC, Marico, Nestle shares in focus as NIFTY FMCG soars nearly 2% on September 16

Marico shares rose 3.6% to an intraday high of ₹819.90 on September 16. This gain occurred as the NIFTY FMCG index increased by 1.8%, driven by a market rebound and positive investor sentiment from festival demand. The company's stock has gained 7% year-to-date.

3 days ago·Read at upstox.com
MARICO

Analysts recommend Colgate-Palmolive, Glenmark Pharma, Marico; IOC gets a sell call

Analysts recommended Marico Limited as a short-term buy opportunity on Wednesday. Market experts based this recommendation on technical and derivative indicators.

3 days ago·Read at CNBC TV18